Ropes & Gray Advises PJT Partners as financial advisor to Stemline Therapeutics in its Sale to Menarini Group
Ropes & Gray advised PJT Partners in its role as financial advisor to Stemline Therapeutics in its sale to Menarini Group. The transaction, which was announced on May 4, was valued at up to $677 million. The press release is here.
PJT Partners is a global advisory-focused investment bank. Stemline Therapeutics Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. The Menarini Group is a privately-held Italian pharmaceutical and diagnostics company.
The New York-based Ropes & Gray team that advised PJT Partners was led by M&A and private equity partner John Sorkin, and included strategic transactions associate Sarah Young.